0.0040
0.0000
(0.00%)
At close: January 30 at 3:00:00 PM EST
Breakdown
9/30/2023
9/30/2022
9/30/2021
9/30/2020
Total Assets
95.6570
85.2760
44.5770
32.9440
Total Liabilities Net Minority Interest
2,051.5660
1,773.8730
2,798.3890
2,707.6320
Total Equity Gross Minority Interest
-1,955.9090
-1,688.5970
-2,753.8120
-2,674.6880
Total Capitalization
-1,955.9090
-1,596.6300
-2,753.8120
-2,674.6880
Common Stock Equity
-1,955.9090
-1,688.5970
-2,753.8120
-2,674.6880
Net Tangible Assets
-1,955.9090
-1,688.5970
-2,753.8120
-2,674.6880
Working Capital
-1,955.9090
-1,596.6300
-2,753.8120
-2,675.0020
Invested Capital
-1,744.9340
-1,468.9100
-2,070.8880
-2,152.8440
Tangible Book Value
-1,955.9090
-1,688.5970
-2,753.8120
-2,674.6880
Total Debt
210.9750
219.6870
682.9240
521.8440
Net Debt
135.9890
180.3240
672.0760
507.6030
Share Issued
771,811.3600
179,979.3610
68,908.0030
68,908.0030
Ordinary Shares Number
771,811.3600
179,979.3610
68,908.0030
68,908.0030
9/30/2020 - 2/24/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ARTH Arch Therapeutics, Inc.
0.1810
0.00%
ELOX Eloxx Pharmaceuticals, Inc.
0.0001
0.00%
RGBP Regen BioPharma, Inc.
0.0621
0.00%
CELC Celcuity Inc.
11.95
+1.96%
ADXS Ayala Pharmaceuticals, Inc.
0.0286
0.00%
PLRX Pliant Therapeutics, Inc.
10.75
+0.84%
PRAX Praxis Precision Medicines, Inc.
76.55
+0.46%
LRMR Larimar Therapeutics, Inc.
3.8400
-3.27%
IMVT Immunovant, Inc.
21.74
-1.50%
ADAP Adaptimmune Therapeutics plc
0.5900
-3.12%